Innovhem is proud to be part of the first promotion of the french accelerator for digital health prevention !
BPI France and PariSanté Campus have set up a high-level program to support 20 French companies and strengthen their strategy to accelerate the market launch of their digital prevention solution.
Innovhem to present New data on single-cell quantification of HbF and HbS at the 2024 ASH Annual Meeting. One poster presentation to feature new...
Innovhem's patents protect our BIOMARKERS : An important news ! SINGLE CELL QUANTIFICATION OF FETAL HEMOGLOBIN patent has been issued in France,...
HEMOPROVE is an Open-label One Stage Phase II study sponsored by AP-HP. The investigator hypothesis is that the treatment by Voxelotor (GBT440) will...
INNOVHEM is part of the 4th promotion of SISTA Entrepreneures with AXA FRANCE. This program aims to support the financing of companies run by women.